U.S. signs law for terminally ill patients to try experimental treatments


President Donald Trump has signed a bill giving terminally ill patients the right to try experimental treatments not approved by the government.

Patients were able to apply to the US Food and Drug Administration (FDA) for access to non-approved drugs before, and most were granted permission.

The new bill does not mandate that drug makers give access to unapproved drugs to patients asking for them.

Advocacy groups including the American Cancer Society had opposed the bill.

The new Right to Try act allows patients with life-threatening diseases to bypass the FDA’s application process for “compassionate use” of experimental drugs.

Patients seeking access to “investigational drugs” now need only the approval of their physician and the drug manufacturer.

The new bill protects doctors and companies from the legal risks of allowing unapproved treatments unless they intentionally harm a patient.

The policy that patients must have exhausted all other approved treatments and clinical trial options remains.

Previous articleNigeria’s local refineries record N14bn deficit
Next articleSecurity: FG lauds Dangote over presentation of 150 patrol cars to Police
Godwin Okafor is a Financial Journalist, Internet Social Entrepreneur and Founder of Naija247news Media Limited. He has over 16 years experience in financial journalism. His experience cuts across traditional and digital media. He started his journalism career at Business Day, Nigeria and founded Naija247news Media in 2010. Godwin holds a Bachelors degree in Industrial Relations and Personnel Management from the Lagos State University, Ojo, Lagos. He is an alumni of Lagos Business School and a Fellow of the University of Pennsylvania (Wharton Seminar for Business Journalists). Over the years, he has won a number of journalism awards. Godwin is the chairman of Emmerich Resources Limited, the publisher of Naija247news.